AF64A-induced brain damage and its relation to dementia
Several data obtained in the AF64A-model are of particular relevance for our understanding of the pathogenesis and progression of Alzheimer’s disease. The AF64A-induced withdrawal of cholinergic function in the rat hippocampus was associated with reversible functional changes in other neurotransmitters, including noradrenaline, serotonin, somatostatin and glutamate, thereby mimicking changes in Alzheimer’s disease. Identical changes in markers for synaptic vesicles were found in Alzheimer’s disease and AF64A-model. A study on the role of gender revealed a higher susceptibility to the neurotoxic action of AF64A in female rats. The cholinergic deficit was also responsible for a disinhibition of the negative feedback regulation of glucocorticoids. Increased exposure to glucocorticoids, however, enhanced the vulnerability of hippocampal cholinergic neurons to AF64A. These data indicate that the AF64A-induced cholinergic deficit in the rat brain represents a reliable tool to study several mechanisms possibly involved in Alzheimer’s disease.
KeywordsSenile Dementia Cholinergic Function ChAT Activity Cholinergic Deficit Choline Acetyltransferase Activity
Unable to display preview. Download preview PDF.
- Davies P, Maloney AJF (1976) Selective loss of central cholinergic neurons in Alzheimer’s disease. Lancet ii: 11–14Google Scholar
- DeLeon MJ, McRae T, Tsai JR, George AE, Maraus DL, Freedman M, Wolf AP, McEwen B (1988) Abnormal Cortisol response in Alzheimer’s disease linked to hippocampal atrophy. Lancet ii: 391–392Google Scholar
- Fendler K, Karmos G, Telegdy G (1961) The effect of hippocampal lesion on pituitary adrenal function. Acta Physiol (Budapest) 20: 283–297Google Scholar
- Hanin I, Fisher A, Hörtnagl H, Leventer SM, Potter PE, Walsh TJ (1987) Ethylcholine aziridinium (AF64A; ECMA) and other potential cholinergic neuron-specific neurotoxins. In: Meitzer HY (ed) Psychopharmacology: the third generation of progress. Raven Press, New York, pp 341–349Google Scholar
- Herman JP, Cullinan WE, Young EA, Akil H, Watson SJ (1992) Selective forebrain fiber tract lesions implicate ventral hippocampal structures in tonic regulation of paraventricular nucleus corticotropin-releasing hormone (CRH) and arginine vasopressin ( AVP) mRNA expression. Brain Res 592: 228–238PubMedCrossRefGoogle Scholar
- Hörtnagl H, Hanin I (1992) Toxins affecting the cholinergic system. In: Herken H, Hucho F (eds) Selective neurotoxicity. Springer, Berlin Heidelberg New York Tokyo, pp 293–332 (Handbook of experimental pharmacology, vol 102 )Google Scholar
- Knigge KM (1961) Adrenocortical response to stress in rats with lesions of hippocampus and amygdala. Proc Soc Exp Biol 108: 67–69Google Scholar
- Mahata SK, Marksteiner J, Sperk G, Mahata M, Gruber B, Fischer-Colbrie R, Winkler H (1992b) Temporal lobe epilepsy of the rat: differential expression of RNA for chromogranin B, secretogranin II, synaptin/synaptophysin and p65 in subfields of the hippocampus. Mol Brain Res 16: 1–12PubMedCrossRefGoogle Scholar
- Potter PE, Härsing LG Jr, Kakucska I, Gaäl G, Vizi ES (1986) Selective impairment of acetylcholine release and content in the central nervous system following intracere- broventricular administration of ethylcholine mustard aziridinium ion (AF64A) in the rat. Neurochem Int 8: 199–206PubMedCrossRefGoogle Scholar
- Ruberg M, Mayo W, Brice A, Duyckaerts C, Hauw JJ, Simon H, LeMoal M, Agid Y (1990) Choline acetyltransferase activity and [3H]vesamicol binding in the temporal cortex of patients with Alzheimer’s disease, Parkinson’s disease and rats with basal forebrain lesions. Neuroscience 35: 327–333PubMedCrossRefGoogle Scholar
- Suemaru S, Hashimoto K, Suemaru K, Maeba Y, Matsushita N, Zensuke O (1991) Hyperkinesia, plasma corticotropin releasing hormone and ACTH in senile dementia. Neuro-Report 2: 337–340Google Scholar